M-TADALAFIL

mantra pharma inc🇨🇦 Health Canada

Approval Id: 20a5f678ae2fff42
Drug Approval Canada Name: M-TADALAFIL
Product Name: M-TADALAFIL
Status: Marketed
Status Date: 2021-09-27
Original Market Date: 2021-09-27
Din: 02512114
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:12.12
Atc Original: G04BE08 TADALAFIL
Atc Name: g 04 be 08
Aig Number: 0149485004
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

TADALAFIL

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

20a5f678ae2fff42

Type

Standard